Literature DB >> 24253313

Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus.

Xiaohong Li1, Patricia C Galipeau, Thomas G Paulson, Carissa A Sanchez, Jessica Arnaudo, Karen Liu, Cassandra L Sather, Rumen L Kostadinov, Robert D Odze, Mary K Kuhner, Carlo C Maley, Steven G Self, Thomas L Vaughan, Patricia L Blount, Brian J Reid.   

Abstract

All cancers are believed to arise by dynamic, stochastic somatic genomic evolution with genome instability, generation of diversity, and selection of genomic alterations that underlie multistage progression to cancer. Advanced esophageal adenocarcinomas have high levels of somatic copy number alterations. Barrett's esophagus is a risk factor for developing esophageal adenocarcinoma, and somatic chromosomal alterations (SCA) are known to occur in Barrett's esophagus. The vast majority (∼95%) of individuals with Barrett's esophagus do not progress to esophageal adenocarcinoma during their lifetimes, but a small subset develop esophageal adenocarcinoma, many of which arise rapidly even in carefully monitored patients without visible endoscopic abnormalities at the index endoscopy. Using a well-designed, longitudinal case-cohort study, we characterized SCA as assessed by single-nucleotide polymorphism arrays over space and time in 79 "progressors" with Barrett's esophagus as they approach the diagnosis of cancer and 169 "nonprogressors" with Barrett's esophagus who did not progress to esophageal adenocarcinoma over more than 20,425 person-months of follow-up. The genomes of nonprogressors typically had small localized deletions involving fragile sites and 9p loss/copy neutral LOH that generate little genetic diversity and remained relatively stable over prolonged follow-up. As progressors approach the diagnosis of cancer, their genomes developed chromosome instability with initial gains and losses, genomic diversity, and selection of SCAs followed by catastrophic genome doublings. Our results support a model of differential disease dynamics in which nonprogressor genomes largely remain stable over prolonged periods, whereas progressor genomes evolve significantly increased SCA and diversity within four years of esophageal adenocarcinoma diagnosis, suggesting a window of opportunity for early detection. ©2013 AACR.

Entities:  

Mesh:

Year:  2013        PMID: 24253313      PMCID: PMC3904552          DOI: 10.1158/1940-6207.CAPR-13-0289

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  64 in total

1.  Long-term follow-up of Barrett's high-grade dysplasia.

Authors:  A P Weston; P Sharma; M Topalovski; R Richards; R Cherian; A Dixon
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

2.  Prognostic impact of nodal micrometastasis in early esophageal cancer.

Authors:  K L Prenzel; A H Hölscher; U Drebber; M Agavonova; C A Gutschow; E Bollschweiler
Journal:  Eur J Surg Oncol       Date:  2012-01-25       Impact factor: 4.424

3.  Overdiagnosis and overtreatment in cancer: an opportunity for improvement.

Authors:  Laura J Esserman; Ian M Thompson; Brian Reid
Journal:  JAMA       Date:  2013-08-28       Impact factor: 56.272

Review 4.  Causes and consequences of aneuploidy in cancer.

Authors:  David J Gordon; Benjamin Resio; David Pellman
Journal:  Nat Rev Genet       Date:  2012-01-24       Impact factor: 53.242

5.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.

Authors:  B J Reid; D S Levine; G Longton; P L Blount; P S Rabinovitch
Journal:  Am J Gastroenterol       Date:  2000-07       Impact factor: 10.864

6.  Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus.

Authors:  D S Levine; P L Blount; R E Rudolph; B J Reid
Journal:  Am J Gastroenterol       Date:  2000-05       Impact factor: 10.864

7.  Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis.

Authors:  Attila Dubecz; Isabell Gall; Norbert Solymosi; Michael Schweigert; Jeffrey H Peters; Marcus Feith; Hubert J Stein
Journal:  J Thorac Oncol       Date:  2012-02       Impact factor: 15.609

8.  Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.

Authors:  Austin M Dulak; Steven E Schumacher; Jasper van Lieshout; Yu Imamura; Cameron Fox; Byoungyong Shim; Alex H Ramos; Gordon Saksena; Sylvan C Baca; Jose Baselga; Josep Tabernero; Jordi Barretina; Peter C Enzinger; Giovanni Corso; Franco Roviello; Lin Lin; Santhoshi Bandla; James D Luketich; Arjun Pennathur; Matthew Meyerson; Shuji Ogino; Ramesh A Shivdasani; David G Beer; Tony E Godfrey; Rameen Beroukhim; Adam J Bass
Journal:  Cancer Res       Date:  2012-07-02       Impact factor: 12.701

9.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.

Authors:  Christina Curtis; Sohrab P Shah; Suet-Feung Chin; Gulisa Turashvili; Oscar M Rueda; Mark J Dunning; Doug Speed; Andy G Lynch; Shamith Samarajiwa; Yinyin Yuan; Stefan Gräf; Gavin Ha; Gholamreza Haffari; Ali Bashashati; Roslin Russell; Steven McKinney; Anita Langerød; Andrew Green; Elena Provenzano; Gordon Wishart; Sarah Pinder; Peter Watson; Florian Markowetz; Leigh Murphy; Ian Ellis; Arnie Purushotham; Anne-Lise Børresen-Dale; James D Brenton; Simon Tavaré; Carlos Caldas; Samuel Aparicio
Journal:  Nature       Date:  2012-04-18       Impact factor: 49.962

10.  Absolute quantification of somatic DNA alterations in human cancer.

Authors:  Scott L Carter; Kristian Cibulskis; Elena Helman; Aaron McKenna; Hui Shen; Travis Zack; Peter W Laird; Robert C Onofrio; Wendy Winckler; Barbara A Weir; Rameen Beroukhim; David Pellman; Douglas A Levine; Eric S Lander; Matthew Meyerson; Gad Getz
Journal:  Nat Biotechnol       Date:  2012-05       Impact factor: 54.908

View more
  73 in total

Review 1.  Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening.

Authors:  Sudhir Srivastava; Brian J Reid; Sharmistha Ghosh; Barnett S Kramer
Journal:  J Cell Physiol       Date:  2016-04-29       Impact factor: 6.384

2.  Genomic Characterization of Esophageal Squamous Cell Carcinoma Reveals Critical Genes Underlying Tumorigenesis and Poor Prognosis.

Authors:  Hai-De Qin; Xiao-Yu Liao; Yuan-Bin Chen; Shao-Yi Huang; Wen-Qiong Xue; Fang-Fang Li; Xiao-Song Ge; De-Qing Liu; Qiuyin Cai; Jirong Long; Xi-Zhao Li; Ye-Zhu Hu; Shao-Dan Zhang; Lan-Jun Zhang; Benjamin Lehrman; Alan F Scott; Dongxin Lin; Yi-Xin Zeng; Yin Yao Shugart; Wei-Hua Jia
Journal:  Am J Hum Genet       Date:  2016-04-07       Impact factor: 11.025

Review 3.  Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  Brian J Reid; Thomas G Paulson; Xiaohong Li
Journal:  Gastroenterology       Date:  2015-07-21       Impact factor: 22.682

Review 4.  Is Barrett's-Associated Esophageal Adenocarcinoma a Clonal Disease?

Authors:  Nicholas A Wright
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

5.  Evaluation of Mutational Testing of Preneoplastic Barrett's Mucosa by Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Endoscopic Samples for Detection of Concurrent Dysplasia and Adenocarcinoma in Barrett's Esophagus.

Authors:  Armando Del Portillo; Stephen M Lagana; Yuan Yao; Takeshi Uehara; Nirag Jhala; Tapan Ganguly; Peter Nagy; Jorge Gutierrez; Aesis Luna; Julian Abrams; Yang Liu; Randall Brand; Jorge L Sepulveda; Gary W Falk; Antonia R Sepulveda
Journal:  J Mol Diagn       Date:  2015-06-08       Impact factor: 5.568

6.  Quantification of Multiple Tumor Clones Using Gene Array and Sequencing Data.

Authors:  Yichen Cheng; James Y Dai; Thomas G Paulson; Xiaoyu Wang; Xiaohong Li; Brian J Reid; Charles Kooperberg
Journal:  Ann Appl Stat       Date:  2017-07-20       Impact factor: 2.083

Review 7.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

8.  Quantitation of spatial and temporal variability of biomarkers for Barrett's Esophagus.

Authors:  J Nwachokor; O Tawfik; M Danley; S Mathur; J House; P Sharma; L K Christenson; A Bansal
Journal:  Dis Esophagus       Date:  2017-09-01       Impact factor: 3.429

9.  Surrogate Markers: Lessons from the Next Gen?

Authors:  Brian J Reid
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-02

Review 10.  The mathematics of cancer: integrating quantitative models.

Authors:  Philipp M Altrock; Lin L Liu; Franziska Michor
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.